Nexium I.V. (Esomeprazole)

Esomeprazole, the active ingredient in Nexium I.V., is a proton pump inhibitor presented as an intravenous solution for intravenous use. It reduces gastric acid secretion and is employed in the management of acid‑related disorders such as erosive oesophagitis, gastro‑oesophageal reflux disease, and the prevention of stress‑related or NSAID‑associated gastric ulcers.

GNH USA supplies Nexium I.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Nexium I.V. (esomeprazole) is a proton pump inhibitor used to manage acid‑related disorders.

- Erosive oesophagitis: promotes healing of damaged esophageal mucosa by reducing gastric acid exposure. - Gastro‑oesophageal reflux disease (GERD): alleviates symptoms and prevents mucosal injury. - Prevention of stress‑related gastric ulcers: reduces risk of ulcer formation in critically ill patients. - Prevention of NSAID‑associated gastric ulcers: protects the stomach lining during NSAID therapy. - Adjunct in Helicobacter pylori eradication therapy: enhances eradication rates when combined with antibiotics.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools that may resolve with continued therapy. - Nausea: feeling of queasiness without vomiting. - Abdominal pain: discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty. - Stevens‑Johnson syndrome/Toxic epidermal necrolysis: rare skin blistering disorders. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Hypomagnesemia: low magnesium levels with prolonged use. - Hepatic enzyme elevation: increased liver function test results.

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: prolonged therapy may cause hypomagnesemia. - Use cautiously in hepatic impairment: dose may need adjustment. - Avoid in known hypersensitivity to esomeprazole or other PPIs. - Pregnancy category B: weigh potential benefits against risks. - Store at room temperature: keep in the original container, protect from light and moisture.

Esomeprazole may interact with several medicines. Review patient medication lists carefully.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption, compromising antiviral efficacy. - Methotrexate: increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring more frequent monitoring. - Digoxin: may raise serum digoxin concentrations. - Diazepam: potential elevation of plasma levels, enhancing sedation.